Product Images Levetiracetam
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Levetiracetam NDC 0615-7979 by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
figure 1 - levetiracetam 1000mg 7979 lupin 1
This text provides a formula for calculating the total daily dose of a medication based on the patient's weight and the daily dose in milligrams per kilogram (mg/kg) of the medication. The medication is available in a concentration of 100 milligrams per milliliter (mg/mL).*
Levetiracetam 1000mg bingo card label - levetiracetam 1000mg 7979 lupin 10
This is a package of Levetiracetam Tablets, USP, with a dosage level of 1000 mg per tablet. The manufacturer is Lupin, with an NDC of 68180-115-07, and the package was packaged by Vanguard in Glasgow, KY. The lot number is 7979. There are various other lot numbers and dosage levels listed on the package, however, they are not clearly identifiable and some of them may be incorrect. The package insert binder for dosage information is included. The package should be stored at 20-25°C (68°- 77°F), and dispensed in a tight, light-resistant container. It is for institutional use only.*
figure 2 - levetiracetam 1000mg 7979 lupin 2
structure - levetiracetam 1000mg 7979 lupin 3
figure 4 - levetiracetam 1000mg 7979 lupin 4
This appears to be a chart or graph with percentages and dosages of a medication called Levetiracetam. The chart shows the dosages of 1000 mg/day and 3000 mg/day for two groups of individuals with sample sizes of 97 and 101 respectively. There are also percentages shown ranging from 45% to 0% with various intervals labeled. Without further context, it is unclear what these percentages represent.*
figure 5 - levetiracetam 1000mg 7979 lupin 5
This appears to be a chart showing the percentage of patients who had some sort of result while taking either a placebo, 1000mg/day of levetiracetam, or 2000mg/day of levetiracetam. There is not enough information or context provided to determine what the results are, or what condition the medication is intended to treat.*
figure 6 - levetiracetam 1000mg 7979 lupin 6
figure 7 - levetiracetam 1000mg 7979 lupin 7
This is a table showing the percentage of patients in a study who received either a placebo or levetiracetam. The percentages range from 0% to 44.6%. However, there are some random characters and symbols interspersed within the data.*
figure 8 - levetiracetam 1000mg 7979 lupin 8
This text represents the efficacy results of Levetiracetam compared to Placebo. Levetiracetam showed a significant improvement in patients as 43.1% of them had positive results, while only 19.6% of patients on Placebo had positive results. The study was conducted with 58 participants for Levetiracetam and 51 participants for Placebo.*
figure 9 - levetiracetam 1000mg 7979 lupin 9
This is a table showing the percentage of patients in two groups (Placebo and Levetiracetam) with numbers of participants in each group. There are no further details available.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.